KRT14 and neoplasm: In our studies, we have utilized a keratin 14 (Krt14)-promoter-driven Cre recombinase to delete floxed Pparg in mice to examine how the loss of epidermal Pparg alters tumorigenesis, contact hypersensitivity, and anti-tumor immune responses [1,27,28,29].